MYLK Antikörper (Middle Region)
Kurzübersicht für MYLK Antikörper (Middle Region) (ABIN953458)
Target
Alle MYLK Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 542-570, Middle Region
-
Spezifität
- This antibody recognizes human MYLK / MYLK3.
-
Aufreinigung
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogen
- Synthetic peptide - KLH conjugated - corresponding to the central region (between 542-570aa) of human MLCK / MYLK3
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MYLK (Myosin Light Chain Kinase (MYLK))
-
Andere Bezeichnung
- MLCK
-
Hintergrund
- Phosphorylation of cardiac myosin heavy chains (like MYH7B) and light chains (like MYL2) by a kinase, such as MYLK3, potentiates the force and rate of cross-bridge recruitment in cardiac myocytes [Chan et al., 2008, PubMed 18202317].Synonyms: MYLK3, Putative myosin light chain kinase 3
-
Molekulargewicht
- 88393 Da
-
Gen-ID
- 91807
-
NCBI Accession
- NP_872299
Target
-